[Evaluation of a new synthetic penicillin--Hetacillin].
D000293:Adolescent; D000328:Adult; D001419:Bacteria / Q000187:drug effects; D001982:Bronchial Diseases / Q000188:drug therapy*; D001996:Bronchopneumonia / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D003556:Cystitis / Q000188:drug therapy; D003967:Diarrhea / Q000188:drug therapy; D004405:Dysentery, Bacillary / Q000188:drug therapy; D004926:Escherichia coli / Q000187:drug effects; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006801:Humans; D007223:Infant; D007273:Injections, Intramuscular; D007410:Intestinal Diseases / Q000188:drug therapy*; D008297:Male; D010406:Penicillins / Q000008:administration & dosage* / Q000494:pharmacology; D012541:Scarlet Fever / Q000188:drug therapy; D014069:Tonsillitis / Q000188:drug therapy*
D010406:Penicillins